CLINICAL_TRIALS
trial_result
· 2023-01-30
Clinical Trial Update: Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis [Phase 3]
Summary
A Phase 3 trial evaluating BMS-986165 (deucravacitinib) versus placebo and active comparator in psoriasis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2023-01-30